Home  >  Products  >  DRAXIN (dorsal inhibitory axon guidance protein ) Blocking Peptide (the C terminal of DRAXIN)(100ug)
DRAXIN (dorsal inhibitory axon guidance protein ) Blocking Peptide (the C terminal of DRAXIN)(100ug)

DRAXIN (dorsal inhibitory axon guidance protein ) Blocking Peptide (the C terminal of DRAXIN)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DRAXIN Antibody (ARP69725_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP69725
Size: 100ug
Weight: 36kDa
Gene: 374946
Format: Lyophilized powder
Target: DRAXIN is a chemorepulsive axon guidance protein required for the development of spinal cord and forebrain commissures. It acts as a chemorepulsive guidance protein for commissural axons during development and is able to inhibit or repel neurite outgrowth from dorsal spinal cord. DRAXIN inhibits the stabilization of cytosolic beta-catenin (CTNNB1) via its interaction with LRP6, thereby acting as an antagonist of Wnt signaling pathway.
Alternative names: AGPA3119; UNQ3119; neucrin
See Full Product Listings >